BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16760764)

  • 1. Diagnosis and therapy in advanced cancer of the esophagus and the gastroesophageal junction.
    Lerut T; Coosemans W; Decker G; De Leyn P; Moons J; Nafteux P; Van Raemdonck D
    Curr Opin Gastroenterol; 2006 Jul; 22(4):437-41. PubMed ID: 16760764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staging and treatment of advanced esophageal cancer.
    von Rahden BH; Stein HJ
    Curr Opin Gastroenterol; 2005 Jul; 21(4):472-7. PubMed ID: 15930991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role and clinical value of EUS in a multimodality esophageal carcinoma staging program with CT and positron emission tomography.
    Pfau PR; Perlman SB; Stanko P; Frick TJ; Gopal DV; Said A; Zhang Z; Weigel T
    Gastrointest Endosc; 2007 Mar; 65(3):377-84. PubMed ID: 17321235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimodality therapy for the curative treatment of cancer of the esophagus and gastroesophageal junction.
    Ku GY; Ilson DH
    Expert Rev Anticancer Ther; 2008 Dec; 8(12):1953-64. PubMed ID: 19046115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer of the gastroesophageal junction: combined modality therapy.
    Ilson DH
    Surg Oncol Clin N Am; 2006 Oct; 15(4):803-24. PubMed ID: 17030275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors in adenocarcinoma of the esophagus or gastroesophageal junction.
    Lagarde SM; ten Kate FJ; Reitsma JB; Busch OR; van Lanschot JJ
    J Clin Oncol; 2006 Sep; 24(26):4347-55. PubMed ID: 16963732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in nasopharyngeal carcinoma.
    Guigay J
    Curr Opin Oncol; 2008 May; 20(3):264-9. PubMed ID: 18391624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evolving role of PET-CT in the management of esophageal cancer.
    Chuang HH; Macapinlac HA
    Q J Nucl Med Mol Imaging; 2009 Apr; 53(2):201-9. PubMed ID: 19293768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of neoadjuvant therapy for esophageal adenocarcinoma.
    Ku GY; Ilson DH
    Surg Oncol Clin N Am; 2009 Jul; 18(3):533-46. PubMed ID: 19500742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-FDG PET and 18F-FDG PET/CT for assessing response to therapy in esophageal cancer.
    Krause BJ; Herrmann K; Wieder H; zum Büschenfelde CM
    J Nucl Med; 2009 May; 50 Suppl 1():89S-96S. PubMed ID: 19380406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is positron emission tomography useful in locoregional staging of esophageal cancer? Results of a multidisciplinary initiative comparing CT, positron emission tomography, and EUS.
    Sandha GS; Severin D; Postema E; McEwan A; Stewart K
    Gastrointest Endosc; 2008 Mar; 67(3):402-9. PubMed ID: 18178202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staging in oesophageal cancer.
    Plukker JT; van Westreenen HL
    Best Pract Res Clin Gastroenterol; 2006; 20(5):877-91. PubMed ID: 16997167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II trial of accelerated multimodality therapy for locoregionally advanced cancer of the esophagus and gastroesophageal junction: the impact of clinical heterogeneity.
    Adelstein DJ; Rice TW; Rybicki LA; Saxton JP; Videtic GM; Murthy SC; Zuccaro G; Vargo JJ; Dumot JA; Carroll MA
    Am J Clin Oncol; 2007 Apr; 30(2):172-80. PubMed ID: 17414467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis, diagnosis and therapeutic possibilities of esophageal cancer.
    Siersema PD
    Curr Opin Gastroenterol; 2007 Jul; 23(4):456-61. PubMed ID: 17545786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant therapy in gastric and cardia cancer: should we irradiate?
    Van Laethem JL; Demols A
    Curr Opin Oncol; 2006 Jul; 18(4):381-5. PubMed ID: 16721135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative therapy in esophageal cancer.
    Ku GY; Ilson DH
    Clin Adv Hematol Oncol; 2008 May; 6(5):371-9. PubMed ID: 18516027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The endoscopic diagnosis and staging of oesophageal adenocarcinoma.
    Bergman JJ
    Best Pract Res Clin Gastroenterol; 2006; 20(5):843-66. PubMed ID: 16997165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of fluorodeoxyglucose-positron emission tomography (FDG-PET) and endoscopic ultrasonography parameters in predicting survival following surgery for esophageal cancer.
    Omloo JM; Sloof GW; Boellaard R; Hoekstra OS; Jager PL; van Dullemen HM; Fockens P; Plukker JT; van Lanschot JJ
    Endoscopy; 2008 Jun; 40(6):464-71. PubMed ID: 18543134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimodality therapy of local regional esophageal cancer.
    Kelsen DP
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S6-10. PubMed ID: 16399422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of T2 esophageal cancer.
    Sancheti M; Fernandez F
    Surg Clin North Am; 2012 Oct; 92(5):1169-78. PubMed ID: 23026276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.